Therapeutic dilemma of fluconazole prophylaxis in intensive care

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 155-159

  Sypula, William T ^a   Kale Pradhan, Pramodini B ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Fluconazole; Intensive care; Surgical prophylaxis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDIASIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG INDICATION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MEDICAL DECISION MAKING; MEDLINE; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT;

EID: 0036140572     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A078     Document Type: Article

References (26)

1. Fluconazole prophylaxis for high-risk liver transplant recipients
2. Efficacy and safety of fluconazole prophylaxis for fungal infections after bone marrow transplantation: A prospective, randomized double-blind study
3. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
4. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units
5. The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit
6. The epidemiology of hematogenous candidiasis caused by different Candida species
7. Effects of fluconazole administration in critically ill patients: Analysis of bacterial and fungal resistance
8. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
9. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: A randomized, double-blind, placebo-controlled trial
10. A double-blind, placebo-controlled trial of prophylactic fluconazole to prevent Candida infections in critically ill surgical patients
11. Fluconazole blood concentrations after enteral administration in critically ill surgical patients exceed most Candida minimal inhibitory concentrations in a double-blind, placebo-controlled trial in which fluconazole prevented candidal infections
12. Fluconazole prophylaxis of severe Candida infection in trauma and postsurgical patients: A prospective, double-blind, randomized, placebo-controlled trial
13. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1990
14. Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
15. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model
16. Candida infections in critically ill trauma patients: A retrospective case-control study
17. Candida colonization and subsequent infections in critically ill surgical patients
18. Clinical significance of Candida isolated from peritoneum in surgical patients
19. Candida albicans translocation across the gut mucosa following burn injury
20. The role of intestinal barrier function and bacterial translocation in the development of systemic infection and multiple organ failure
21. Pathogenicity determinants of Candida
22. Host parasite relationships in candidiasis
23. Practice guidelines for the treatment of candidiasis
24. Prophylactic antifungal therapy in the intensive care unit